Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
silibrin (1 trial)
Hepatic Insufficiency (Phase 3)
Liver Failure (Phase 3)
Mushroom Poisoning (Phase 3)
Poisoning (Phase 3)
Trials (1 total)
Trial APIs (1 total)